Kamal Medico Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.89 M
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.09 Cr
About Kamal Medico
Kamal Medico Private Limited (KMPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 November 1988 and has a history of 36 years and two months. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.89 M.
The company currently has active open charges totaling ₹3.09 Cr.
Jiten Vora, Viresh Vora, Kamal Vora, and One other member serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1988PTC049777
-
Company No.
049777
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Nov 1988
-
Date of AGM
05 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kamal Medico?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jiten Vora
|
Whole-Time Director | 25-Nov-1988 | Current |
|
Viresh Vora
|
Whole-Time Director | 25-Nov-1988 | Current |
|
Kamal Vora
|
Whole-Time Director | 25-Nov-1988 | Current |
|
Malav Vora
|
Whole-Time Director | 01-Apr-2004 | Current |
Financial Performance of Kamal Medico.
Kamal Medico Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kamal Medico?
In 2023, Kamal Medico had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹30.92 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.04 Cr
- The Saraswat Co-Op Bank Ltd : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jan 2022 | Others | ₹5.40 M | Open |
| 25 Oct 1994 | The Saraswat Co-Op Bank Ltd | ₹0.46 M | Open |
| 01 Apr 1989 | Others | ₹2.50 Cr | Open |
| 01 Apr 1989 | The Saraswat Co-Op Bank Ltd | ₹0.06 M | Open |
How Many Employees Work at Kamal Medico?
Kamal Medico has a workforce of 130 employees as of Apr 19, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kamal Medico, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kamal Medico's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
